Cite
HARVARD Citation
Yamasaki, F. et al. (n.d.). COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS. Neuro-oncology advances. p. ii43. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamasaki, F. et al. (n.d.). COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS. Neuro-oncology advances. p. ii43. [Online].